|
Volumn 26, Issue 4, 2006, Pages 421-424
|
Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
CEFOPERAZONE;
HETEROCYCLIC COMPOUND;
MOXIFLOXACIN;
QUINOLINE DERIVATIVE;
ADOLESCENT;
ADULT;
ARTICLE;
BACTERIAL PNEUMONIA;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTI-INFECTIVE AGENTS;
AZA COMPOUNDS;
AZITHROMYCIN;
CEFOPERAZONE;
COMMUNITY-ACQUIRED INFECTIONS;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
PNEUMONIA, BACTERIAL;
QUINOLINES;
TREATMENT OUTCOME;
|
EID: 44649106400
PISSN: 16720733
EISSN: None
Source Type: Journal
DOI: 10.1007/s11596-006-0411-0 Document Type: Article |
Times cited : (15)
|
References (0)
|